Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory

BACKGROUND: To cure drug-resistant (DR) tuberculosis (TB), the antituberculous treatment should be guided by Mycobacterium tuberculosis drug-susceptibility testing (DST). In this study, we compared conventional DST performed in Minsk, Belarus, a TB DR high-burden country, with extensive geno- and ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Podlekareva, Daria N., Folkvardsen, Dorte Bek, Skrahina, Alena, Vassilenko, Anna, Skrahin, Aliaksandr, Hurevich, Henadz, Klimuk, Dzmitry, Karpov, Igor, Lundgren, Jens D., Kirk, Ole, Lillebaek, Troels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035031/
https://www.ncbi.nlm.nih.gov/pubmed/33868727
http://dx.doi.org/10.1155/2021/6646239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035031/
https://www.ncbi.nlm.nih.gov/pubmed/33868727
http://dx.doi.org/10.1155/2021/6646239

Ejemplares similares